flacon+seringue

Controlled release technology

Discover our proprietary, game-changing technology platform for the next generation of controlled and sustained drug delivery thanks to its flexibility and low manufacturing cost. Its physicochemical properties make it an ideal vehicle for a broad variety of Active Pharmaceutical Ingredients (APIs). read more
stones2

Best in class products

Burst control, flexible duration control, broad API compatibility, low manufacturing costs, compliance improvement, rapid formulation, reduced environmental impacts: our biodegradable polymer controlled release technology offers a balanced approach and all benefits to create best in class products. read more
applications2

Applications

Because chronic pathologies and many human diseases require one or more daily treatments - in some cases for a period of several weeks, months or years, our biodegradable polymer controlled release technology represents a significant benefit in dosage profiles and patient care. read more

Share the vision?

We innovate for Global Health

With existing pharmaceutical business models, global health markets have a challenge to address. In order to service this truly global market, MedinCell is dedicated to innovation to deliver revolutionary medical treatments technologies to the global community, regardless of local economic conditions. We are empowering our partners to develop the next generation of best in class medicines that incorporate potent ecological and compliance-related benefits.

Improving worldwide access to medicine is a goal that cannot be achieved without robust financial success and careful planning.  Free of external financial interests and focused on global health, we incorporate scientific and humanitarian goals into our business as long-term strategic objectives. As a hybrid organization, we work simultaneously on for-profit and non-profit activities.

MedinCell is a self-funded and employee-owned entity. Our success is due to the skills and commitment of our employees. To attract and retain the best talents in the biotechnological and pharmaceutical industry, we offer a proactive and creative environment where individuals can participate and contribute to the overall success of the company.  read more

We are MedinCell

DOUAT-CHRISTOPHE

Christophe DOUAT

Executive

ENAULT-SEBASTIEN

Sébastien Enault

Business Development

REY_ELODIE

Elodie Rey

Research

ROBERGE_CHRISTOPHE

Christophe Roberge

Research

BARBE_ANNE-LAURE2

Anne-Laure Barbe

Research

BANCELINSELINSKY_VICTOIRE

Victoire Bancelin-Selinsky

Human Resources

LECONET_WILHEM

Wilhem Leconet

Research

BONIN_STEPHANIE

Stéphanie Bonnin

Research

MONTEIRO_DOMINGOS

Domingos Monteiro

Research

GERAUD_DANAE_1118

Danae GERAUD

Executive

KROLL_MAX

Max Kroll

Research

GEISSMAN_CAMILLE

Camille Geissmann

Marketing

RECH_ANTHONY

Anthony RECH

Research

BUKS_RALFS

Ralfs Buks

Research

GRIZOT_SYLVESTRE

Sylvestre Grizot

Research

RENE-ADELINE

Adeline René

Research

JULIEN-MELANIE

Melanie Julien

Research

NGUYEN-ANH

Anh Nguyen

Executive

CROS_JEAN-MANUEL

Jean-Manuel Cros

Research

BRIAULT-AURELIE

Aurélie Briault

Research

DEDIEU_MARIELLE

Marielle Dedieu

Administration

PETIT_AUDREY

Audrey Petit

Research

MAURIN_DAMIEN

Damien Maurin

Administration

LIULOPEZ_FANG

Fang Liu-Lopez

Research

CARLUER-MELANIE

Mélodie Carluer

Research

JACQUOT-BENJAMIN

Benjamin Jacquot

Administration

COURJAUD_ANNE-LAURE

Anne-Laure Courjaud

Research

HEUZE_DAVID

David HEUZE

Communication

ALMERAS_RACHEL

Rachel Almeras

Research